Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Advanced Medicine

Manufacture Advanced Medicine

Cost of a Cure

| James Strachan

Gene therapies (including CAR T) could add $45 billion to US healthcare costs over the next five years, a CVS health report finds.

Manufacture Advanced Medicine

Manufacturing by Design

| Frederic Revah

Let’s reduce gene therapy manufacturing costs by optimizing cell lines, improving transfectants, and optimizing downstream purification.

Manufacture Advanced Medicine

The Pharmaceutical Nomad

| James Strachan

Sitting Down With... Miguel Forte, Chief Executive Officer at Bone Therapeutics, Belgium, to discuss advanced medicine.

Manufacture Advanced Medicine

Hands Off the Goods

| Chris Procyshyn

Aseptic filling is the final manufacturing step but it shouldn’t be an afterthought.

Manufacture Advanced Medicine

Point of Care, Point of Commercialization

| James Strachan

UC Davis joins Orgenesis’ point-of-care network to develop and commercialize cell and gene therapies in house.

Manufacture Advanced Medicine

Driving CAR T Cell Therapy

| James Strachan

John Rossi, Director of Translational Sciences at Kite Pharma, talks about bright future of CAR T cell therapy.

Manufacture Advanced Medicine

How to Commercialize a CAR T Cell Therapy

| James Strachan

Dick Sundh, Head of Europe at Kite, explains what it takes to commercialize CAR T cell therapy.

Manufacture Advanced Medicine

Ahead of the Curve

| James Strachan

Ravi Nalliah explains his journey from biochemistry and molecular biology student, to chartered accountant, to supply chain CDMO founder.

Manufacture Advanced Medicine

CAR T Cell Therapy: Redefining Quality

| Bethany Dudek

Here we explore the challenges involved in ensuring CAR T cell therapies are delivered to patients safely and as quickly as possible.

Discovery & Development Advanced Medicine

Where's the Off Switch?!

| Stephanie Sutton

Researchers seek a way to inactivate CAR-T cells in case of adverse effects.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register